ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000272264.1	Ponatinib	Bladder urothelial carcinoma	0.017233677	Sensitive
ENSG00000272264.1	Ponatinib	Colon adenocarcinoma	0.003247355	Resistant